Kyverna Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Kyverna Therapeutics, Inc. quarterly Nonoperating Income (Expense) history and growth rate from Q1 2023 to Q3 2024.
  • Kyverna Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $4.28M, a 424% increase year-over-year.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.28M +$3.46M +424% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $4.63M +$4.42M +2095% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.67M +$2.36M +782% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $817K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $211K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $302K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.